The Kidney Disease Initiative and the Division of Diabetes Translation at the Centers for Disease Control and Prevention
Section snippets
Surveillance and Epidemiology
The CDC is collaborating with partners from the University of Michigan and Johns Hopkins University to develop and establish a surveillance system for all stages of CKD that could monitor national trends and identify research needs. This activity entails identifying the relevant data sources and measures for a CKD surveillance system that would work seamlessly with other kidney-related surveillance efforts, such as the US Renal Data System (USRDS) and the National Diabetes Surveillance System
The DDT at the CDC
Through the DDT, the CDC seeks to eliminate the preventable burden of diabetes through leadership, research, programs, and policies that translate science into practice. The CDC works with partners to provide a national surveillance system for diabetes, provide support and recommendations for public health decisions, promote management practices to ensure good care and education for people with diabetes, and inform the public about the disease.
A key component of the DDT surveillance activities
Conclusion
The CDC will continue to work with its partners to strengthen the surveillance of diabetes and its complications (including kidney disease) and support prevention research, public health interventions, and education. In the case of CKD, increased awareness, early detection and evaluation, and improved treatment for patients with the earlier disease stages and its risk factors are critical to delay or prevent the development, progression, and complications of this disease in the population at
Acknowledgements
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.
Support: None.
Financial Disclosure: None.
References (33)
- et al.
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
Am J Kidney Dis
(2003) - et al.
Deaths: Preliminary Data for 2006
Natl Vital Stat Rep
(2008) - et al.
Prevalence of chronic kidney disease in the United States
JAMA
(2007) USRDS 2007 Annual Data Report
(2007)- et al.
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
N Engl J Med
(2001) National Diabetes Surveillance System
Kidney Disease Initiative
Health ABC Description
Kidney Early Evaluation Program (KEEP) annual data report 2006
Am J Kidney Dis
(2007)Healthy People 2010With Understanding and Improving Health and Objectives for Improving Health
(2000)
Nephropathy in diabetes
Diabetes Care
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
N Engl J Med
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Lancet
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
BMJ
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)
BMJ
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
N Engl J Med
Cited by (9)
Hydration and Health
2019, Analysis in Nutrition Research: Principles of Statistical Methodology and Interpretation of the ResultsHydration and health
2018, Analysis in Nutrition Research: Principles of Statistical Methodology and Interpretation of the ResultsProtective role of aerial parts of silene villosa alcoholic extract against ccl<inf>4</inf>-induced cardiac and renal toxicity in rats
2018, International Journal of PharmacologyRenal nerve ablation for hypertensive patients with chronic kidney disease
2014, Current Vascular Pharmacology